Aurora: Investor Presentation

Select Portfolio of Clinical Studies Indication Cancer Pain Management Osteoarthritis Epilepsy Tourette's Syndrome Pharmacokinetics Epilepsy Genetics Chronic Pain Multiple Medical Conditions Research Partners OCOG, Sunnybrook Health Science Center, Hamilton Health Sciences, Juravinski Cancer Center McGill University Health Network & Queen Elizabeth II Health Science Center Royal University Hospital and University of Saskatchewan University Health Network N.A. Ontario Brain Institute, UofT, University Health Network, University Hospital London, Toronto Western Hospital Mount Sinai Hospital CFL Alumni Association, CannaConnect Clinic University of Alberta Trial Name Cannabis Oil for Pain Effectiveness Vaporized Cannabis for Painful Osteoarthritis of the Knee CBD in Children with Refractory Epilepsy Vaporized Cannabis in Adults with Tourette's Syndrome Comparative Bioavailability and Pharmacogenomics Study of THC on Healthy Volunteers CBD and THC Given as Adjunctive Therapy to Adults with Refractory Seizures Identification of Genetic Biomarker Signatures associated with Cannabis Efficacy and Dose in Survey Patients Assessing the Effects of Medical Cannabis on Pain and Related Quality of Life in Retired Athletes with Chronic Pain Health and Economics-Based Outcomes of Cannabis-Based Therapies Phase lla || || 1 ||| N.A. N.A. N.A. AURORA 23

View entire presentation